Direct emissions
31,818
tCO2e
C
Cohance Lifesciences Limited
Explore carbon emissions data for Cohance Lifesciences Limited. Mycelium helps you review reported emissions, disclosure status, Scope 1, Scope 2 and Scope 3 data, climate targets and sustainability information in one company profile.
This profile brings together available carbon emissions data for Cohance Lifesciences Limited, including reported figures, modelled estimates, disclosure documents and sustainability indicators, so you can review its emissions and compare its performance against similar companies. Read how we source and check this data.
Emissions
Carbon emissions
Total yearly emissions across all scopes
125,395 tCO2e
Scope 1
tCO2e
31,818
Scope 2
tCO2e
25,410
Scope 3 total
tCO2e
68,167
Scope 3 reported
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
Provenance
Emissions
Factors
1,283,854
kgCO2e / £M
Supplier specific emission factors (kgCO2e / £M)
Modelled
Reported
Scope 1 + 2
Direct + purchased energy
585,927
585,927
Upstream
+ upstream Scope 3
632,117
585,927
Total
+ all Scope 3
1,283,854
1,139,324
Which figure should I use?
Use Modelled. It is the most complete view: any categories the company hasn't disclosed are filled with industry-typical estimates, so a transparent company isn't unfairly penalised against one that simply hasn't reported.
Reported counts only emissions the company has filed itself. A blank or low Reported cell doesn't mean those emissions don't exist, just that the company hasn't disclosed them.
When Reported sits close to Modelled, that is a positive signal. The company has disclosed most of its salient emissions and there's little gap for the model to fill. Even then, Modelled is the right figure to use for a like-for-like comparison across companies.
Sustainability
Snapshot
Based on reported data, retrieved with AI
- Cohance Lifesciences Limited reported 125,395 tCO₂e in 2025.
- Scope 3 accounted for 54% of emissions.
- Total emissions increased 30.0% from 2023.
- Disclosures available for 2 reporting years (since 2023).
According to available emissions disclosures, Cohance Lifesciences Limited reported total yearly emissions of 125,395 tCO₂e in 2025. Scope 3 emissions accounted for 54% of reported output, indicating supply chain activity, purchased goods and services, business travel, and wider operational dependencies were the most significant contributors to the company's carbon footprint.
The company achieved a Mycelium Score of 0.1, placing it well below average for its sector for sustainability performance, and received a transparency score of 3.0, pointing to very little public detail on their key emissions.
Total Emissions across all scopes
125,395 tCO2e
Scope 1 emissions
Direct emissions from sources the company owns or controls, such as fuel use, facilities and vehicles.
Scope 2 emissions
Indirect emissions from purchased energy, including electricity, heating and cooling.
Location based
25,410
tCO2eMarket based
–
tCO2eScope 3 emissions
Wider value chain emissions across the 15 GHG Protocol categories, from purchased goods and business travel to investments, where reported.
Cat 1
Purchased goods & services
3,493
tCO2eCat 2
Capital goods
146
tCO2eCat 3
Fuel & energy related activities
146
tCO2eCat 4
Upstream transportation & distribution
146
tCO2eCat 5
Waste generated in operations
146
tCO2eCat 6
Business travel
146
tCO2eCat 7
Employee commuting
146
tCO2eCat 8
Upstream leased assets
146
tCO2eCat 9
Downstream transportation & distribution
146
tCO2eCat 10
Processing of sold products
146
tCO2eCat 11
Use of sold products
8,732
tCO2eCat 12
End-of-life treatment of sold products
146
tCO2eCat 13
Downstream leased assets
146
tCO2eCat 14
Franchises
146
tCO2eCat 15
Investments
146
tCO2e15 values were derived via Mycelium's normalisation process rather than reported by the company. Cells marked “–” were not disclosed.
Climate targets
Science Based Targets initiative
Near-term target
Targets set (1.5°C), target year 2033
Long-term target
Targets set, target year 2050
Net zero
Targets set, by 2050
Source: Science Based Targets initiative, Companies Taking Action.
Contact Info
Website
www.suvenpharm.comAddress
215 ATRIUM C WING 8TH FLOOR 819-821
ANDHERI KURLA ROAD
CHAKALA MIDC
MUMBAI
400093
Country
India
Browse carbon emissions data by industry
Jump straight into the sectors users explore most, or view all industries.
How scoring works
How the Mycelium Score is calculated
The Mycelium Score is out of 10. Up to 6.5 points reflect carbon intensity vs sector peers (emissions normalised against revenue). The remaining 3.5 reflect data quality: third-party verified, profile claimed by the company, and full disclosure across all reporting categories.
A higher score means lower carbon intensity than sector peers, backed by data that's third-party verified, claimed by the company, and fully disclosed. Cohance Lifesciences Limited's score sits at the top of this page and in the score panel.
How the Transparency Score is calculated
The Transparency Score measures how much of a company's key emissions data is publicly disclosed, graded from A (very high) down to F (very low). Crucially, it weights each gap by how material that bucket is for the company's industry, so an undisclosed category where the bulk of emissions sit hurts far more than a minor one.
For Cohance Lifesciences Limited, the single biggest gap is Use of sold products (Scope 3 Category 11). Mycelium estimates it accounts for around 12% of the company's total footprint, typically the largest source of emissions for a Health Care company, yet it hasn't been disclosed. Leaving a bucket this large unreported is what's holding the transparency score down.
Other material categories Cohance Lifesciences Limited hasn't disclosed:
- Purchased goods & services (Scope 3 Category 1), around 5% of the estimated footprint
In total, roughly 17% of Cohance Lifesciences Limited's estimated emissions sit in categories it hasn't reported. Disclosing these would be the fastest way to raise the transparency score.
Read the full scoring methodology
Our white paper covers exactly how the Mycelium Score and Transparency Score are calculated, including the normalisation process and what earns a 10/10.
Download the white paper (PDF)
Cohance Lifesciences Limited carbon emissions FAQs
What are Cohance Lifesciences Limited's carbon emissions?
In its 2025 reporting year, Cohance Lifesciences Limited disclosed total emissions of 125,395 tCO2e across all scopes. Scope 3 accounted for the largest share, around 54% of the total.
Does Cohance Lifesciences Limited report Scope 1, Scope 2 and Scope 3 emissions?
For 2025, Cohance Lifesciences Limited's available disclosure covers Scope 1 (31,818 tCO2e), Scope 2 (25,410 tCO2e). Figures not reported by the company are shown as modelled estimates and labelled as such.
How transparent is Cohance Lifesciences Limited's emissions reporting?
Cohance Lifesciences Limited has a Mycelium transparency score of 3 out of 100. The score weights each emissions category by how material it is for the company's industry, so it reflects whether the disclosures that matter most have been made.
Is Cohance Lifesciences Limited sustainable?
Mycelium measures sustainability through carbon emissions data rather than giving a yes or no verdict. Cohance Lifesciences Limited has a Mycelium Score of 0.1 out of 10, which reflects its emissions intensity against sector peers together with how transparent and well-verified its reporting is. The emissions figures, disclosure documents and climate targets on this page give the fuller picture.
Is Cohance Lifesciences Limited environmentally friendly?
Carbon emissions are one measurable part of environmental impact, and the part Mycelium tracks. Cohance Lifesciences Limited disclosed 125,395 tCO2e for 2025, and its Mycelium Score of 0.1 out of 10 shows how that performance compares with similar companies in its sector.
Learn more about our methodology and where this data comes from.
